Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 3635

1.

Synovial chondromatosis and soft tissue chondroma: extraosseous cartilaginous tumor defined by FN1 gene rearrangement.

Amary F, Perez-Casanova L, Ye H, Cottone L, Strobl AC, Cool P, Miranda E, Berisha F, Aston W, Rocha M, O'Donnell P, Pillay N, Tirabosco R, Baumhoer D, Hookway ES, Flanagan AM.

Mod Pathol. 2019 Dec;32(12):1762-1771. doi: 10.1038/s41379-019-0315-8. Epub 2019 Jul 4.

2.

GLI1-amplifications expand the spectrum of soft tissue neoplasms defined by GLI1 gene fusions.

Agaram NP, Zhang L, Sung YS, Singer S, Stevens T, Prieto-Granada CN, Bishop JA, Wood BA, Swanson D, Dickson BC, Antonescu CR.

Mod Pathol. 2019 Nov;32(11):1617-1626. doi: 10.1038/s41379-019-0293-x. Epub 2019 Jun 12.

3.

Colorectal carcinoma with double somatic mismatch repair gene inactivation: clinical and pathological characteristics and response to immune checkpoint blockade.

Wang T, Lee LH, Vyas M, Zhang L, Ganesh K, Firat C, Segal NH, Desai A, Hechtman JF, Ntiamoah P, Weiser MR, Markowitz AJ, Vakiani E, Klimstra DS, Stadler ZK, Shia J.

Mod Pathol. 2019 Oct;32(10):1551-1562. doi: 10.1038/s41379-019-0289-6. Epub 2019 Jun 7.

4.

Histone H3K27 dimethyl loss is highly specific for malignant peripheral nerve sheath tumor and distinguishes true PRC2 loss from isolated H3K27 trimethyl loss.

Marchione DM, Lisby A, Viaene AN, Santi M, Nasrallah M, Wang LP, Williams EA, Larque AB, Chebib I, Garcia BA, Wojcik JB.

Mod Pathol. 2019 Oct;32(10):1434-1446. doi: 10.1038/s41379-019-0287-8. Epub 2019 Jun 7.

5.

Incidence and distribution of UroSEEK gene panel in a multi-institutional cohort of bladder urothelial carcinoma.

Eich ML, Rodriguez Pena MDC, Springer SU, Taheri D, Tregnago AC, Salles DC, Bezerra SM, Cunha IW, Fujita K, Ertoy D, Bivalacqua TJ, Tomasetti C, Papadopoulos N, Kinzler KW, Vogelstein B, Netto GJ.

Mod Pathol. 2019 Oct;32(10):1544-1550. doi: 10.1038/s41379-019-0276-y. Epub 2019 Apr 25.

6.

Detecting MYB and MYBL1 fusion genes in tracheobronchial adenoid cystic carcinoma by targeted RNA-sequencing.

Pei J, Flieder DB, Patchefsky A, Talarchek JN, Cooper HS, Testa JR, Wei S.

Mod Pathol. 2019 Oct;32(10):1416-1420. doi: 10.1038/s41379-019-0277-x. Epub 2019 Apr 25.

7.

Distinctive mechanisms underlie the loss of SMARCB1 protein expression in renal medullary carcinoma: morphologic and molecular analysis of 20 cases.

Jia L, Carlo MI, Khan H, Nanjangud GJ, Rana S, Cimera R, Zhang Y, Hakimi AA, Verma AK, Al-Ahmadie HA, Fine SW, Gopalan A, Sirintrapun SJ, Tickoo SK, Reuter VE, Gartrell BA, Chen YB.

Mod Pathol. 2019 Sep;32(9):1329-1343. doi: 10.1038/s41379-019-0273-1. Epub 2019 Apr 12.

8.

Immunoreactivity for prostate specific antigen and Ki67 differentiates subgroups of prostate cancer related to outcome.

Hammarsten P, Josefsson A, Thysell E, Lundholm M, Hägglöf C, Iglesias-Gato D, Flores-Morales A, Stattin P, Egevad L, Granfors T, Wikström P, Bergh A.

Mod Pathol. 2019 Sep;32(9):1310-1319. doi: 10.1038/s41379-019-0260-6. Epub 2019 Apr 12.

9.

Combined quantitative measures of ER, PR, HER2, and KI67 provide more prognostic information than categorical combinations in luminal breast cancer.

Abubakar M, Figueroa J, Ali HR, Blows F, Lissowska J, Caldas C, Easton DF, Sherman ME, Garcia-Closas M, Dowsett M, Pharoah PD.

Mod Pathol. 2019 Sep;32(9):1244-1256. doi: 10.1038/s41379-019-0270-4. Epub 2019 Apr 11.

10.

Stage IV lung carcinoids: spectrum and evolution of proliferation rate, focusing on variants with elevated proliferation indices.

Rekhtman N, Desmeules P, Litvak AM, Pietanza MC, Santos-Zabala ML, Ni A, Montecalvo J, Chang JC, Beras A, Preeshagul IR, Sabari JK, Rudin CM, Ladanyi M, Klimstra DS, Travis WD, Lai WC.

Mod Pathol. 2019 Jul;32(8):1106-1122. doi: 10.1038/s41379-019-0248-2. Epub 2019 Mar 28.

11.

Comparing histologic evaluation of prostate tissue using nonlinear microscopy and paraffin H&E: a pilot study.

Cahill LC, Fujimoto JG, Giacomelli MG, Yoshitake T, Wu Y, Lin DI, Ye H, Carrasco-Zevallos OM, Wagner AA, Rosen S.

Mod Pathol. 2019 Jul;32(8):1158-1167. doi: 10.1038/s41379-019-0250-8. Epub 2019 Mar 26.

12.

Immunohistochemical detection of PD-L1 among diverse human neoplasms in a reference laboratory: observations based upon 62,896 cases.

O'Malley DP, Yang Y, Boisot S, Sudarsanam S, Wang JF, Chizhevsky V, Zhao G, Arain S, Weiss LM.

Mod Pathol. 2019 Jul;32(7):929-942. doi: 10.1038/s41379-019-0210-3. Epub 2019 Feb 13.

13.

Three-dimensional analysis reveals two major architectural subgroups of prostate cancer growth patterns.

Verhoef EI, van Cappellen WA, Slotman JA, Kremers GJ, Ewing-Graham PC, Houtsmuller AB, van Royen ME, van Leenders GJLH.

Mod Pathol. 2019 Jul;32(7):1032-1041. doi: 10.1038/s41379-019-0221-0. Epub 2019 Feb 8.

14.

Reply to Reimann et al.

Clarke LE, Leachman SA.

Mod Pathol. 2019 May;32(5):725-727. doi: 10.1038/s41379-018-0197-1. Epub 2019 Jan 21. No abstract available.

15.

NEAT1-TFE3 and KAT6A-TFE3 renal cell carcinomas, new members of MiT family translocation renal cell carcinoma.

Pei J, Cooper H, Flieder DB, Talarchek JN, Al-Saleem T, Uzzo RG, Dulaimi E, Patchefsky AS, Testa JR, Wei S.

Mod Pathol. 2019 May;32(5):710-716. doi: 10.1038/s41379-018-0191-7. Epub 2019 Jan 8.

16.

Pancreatic cancer arising in the remnant pancreas is not always a relapse of the preceding primary.

Luchini C, Pea A, Yu J, He J, Salvia R, Riva G, Weiss MJ, Bassi C, Cameron JL, Hruban RH, Goggins M, Wolfgang CL, Scarpa A, Wood LD, Lawlor RT.

Mod Pathol. 2019 May;32(5):659-665. doi: 10.1038/s41379-018-0183-7. Epub 2018 Nov 22.

17.

Diagnosis of known sarcoma fusions and novel fusion partners by targeted RNA sequencing with identification of a recurrent ACTB-FOSB fusion in pseudomyogenic hemangioendothelioma.

Zhu G, Benayed R, Ho C, Mullaney K, Sukhadia P, Rios K, Berry R, Rubin BP, Nafa K, Wang L, Klimstra DS, Ladanyi M, Hameed MR.

Mod Pathol. 2019 May;32(5):609-620. doi: 10.1038/s41379-018-0175-7. Epub 2018 Nov 21.

18.

Comparison of the genomic background of MET-altered carcinomas of the lung: biological differences and analogies.

Castiglione R, Alidousty C, Holz B, Wagener S, Baar T, Heydt C, Binot E, Zupp S, Kron A, Wolf J, Merkelbach-Bruse S, Reinhardt HC, Buettner R, Schultheis AM.

Mod Pathol. 2019 May;32(5):627-638. doi: 10.1038/s41379-018-0182-8. Epub 2018 Nov 20.

19.

Large cribriform growth pattern identifies ISUP grade 2 prostate cancer at high risk for recurrence and metastasis.

Hollemans E, Verhoef EI, Bangma CH, Rietbergen J, Helleman J, Roobol MJ, van Leenders GJLH.

Mod Pathol. 2019 Jan;32(1):139-146. doi: 10.1038/s41379-018-0157-9. Epub 2018 Oct 22.

20.

Targeted next-generation sequencing of endometrial cancer and matched circulating tumor DNA: identification of plasma-based, tumor-associated mutations in early stage patients.

Bolivar AM, Luthra R, Mehrotra M, Chen W, Barkoh BA, Hu P, Zhang W, Broaddus RR.

Mod Pathol. 2019 Mar;32(3):405-414. doi: 10.1038/s41379-018-0158-8. Epub 2018 Oct 12.

Supplemental Content

Loading ...
Support Center